Litigation Details for AstraZeneca AB v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
✉ Email this page to a colleague
AstraZeneca AB v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-10-26 |
| Court | District Court, D. Delaware | Date Terminated | 2019-12-04 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 10,166,247; 7,759,328; 7,967,011; 8,143,239; 8,575,137 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AstraZeneca AB v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for AstraZeneca AB v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-10-26 | 1 | expiration of U.S. Patent Nos. 7,759,328 (“the ’328 patent”), 8,143,239 (“the ’239 patent”), 8,575,137 (“… The Patents-in-Suit 8. United States Patent No. 7,759,328 (“the ’328 patent”), entitled…of the ’328 patent. 10. United States Patent No. 8,143,239 (“the ’239 patent”), entitled…of the ’137 patent. 14. United States Patent No. 7,967,011 (“the ’011 patent”), entitled… This is a civil action for patent infringement arising under the patent laws of the United States, | External link to document | |
| 2019-12-02 | 116 | Consent Judgment - Proposed | United States Patent Numbers 7,759,328, 8,143,239, 8,575,137, 7,967,011, and 10,166,247, on its own part…2018 4 December 2019 1:18-cv-01685 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
